Page last updated: 2024-08-22

glucosamine and Cardiovascular Diseases

glucosamine has been researched along with Cardiovascular Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Chen, H; Hu, Y; Qin, X; Wang, M; Wang, S; Wu, J; Wu, T; Wu, Y; Yang, R; Yu, H; Zhan, S1
Chen, Q; Chung, VC; Fu, Q; Gao, X; Huang, QM; Kraus, VB; Li, FR; Li, ZH; Lv, YB; Mao, C; Shen, D; Shi, XM; Song, WQ; Wang, ZH; Wu, XB; Yang, X; Zhang, PD; Zhang, XR; Zhong, WF1
Mansournia, MA; Safiri, S1
Herrero-Beaumont, G; Largo, R1
Anderson, JL; Connelly, MA; Galenko, O; Knowlton, KU; Lappe, DL; May, HT; Muhlestein, JB; Otvos, JD1
Gustat, J; Heianza, Y; Ley, SH; Li, X; Ma, H; Qi, L; Sun, D; Zhou, T1
Lie, D; Najm, W1

Other Studies

7 other study(ies) available for glucosamine and Cardiovascular Diseases

ArticleYear
Glucosamine Use Is Associated with a Higher Risk of Cardiovascular Diseases in Patients with Osteoarthritis: Results from a Large Study in 685,778 Subjects.
    Nutrients, 2022, Sep-07, Volume: 14, Issue:18

    Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Glucosamine; Humans; Longitudinal Studies; Male; Middle Aged; Osteoarthritis; Retrospective Studies; Risk Factors; Stroke

2022
Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:6

    Topics: Cardiovascular Diseases; Dietary Supplements; Digestive System Diseases; Female; Glucosamine; Humans; Male; Middle Aged; Mortality; Neoplasms; Proportional Hazards Models; Prospective Studies; Respiratory Tract Diseases; United Kingdom

2020
Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked.
    Annals of the rheumatic diseases, 2022, Volume: 81, Issue:5

    Topics: Cardiovascular Diseases; Causality; Cause of Death; Glucosamine; Humans

2022
Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10

    Topics: Acetylation; Animals; Cardiovascular Diseases; Glucosamine; Humans; Inflammation; Osteoarthritis

2020
GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    American heart journal, 2018, Volume: 202

    Topics: Acetylglucosamine; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glucosamine; Glycoproteins; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment

2018
Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.
    BMJ (Clinical research ed.), 2019, 05-14, Volume: 365

    Topics: Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Follow-Up Studies; Glucosamine; Humans; Osteoarthritis; Pain; Prospective Studies; Risk Factors; Stroke; United Kingdom

2019
Dietary supplements commonly used for prevention.
    Primary care, 2008, Volume: 35, Issue:4

    Topics: Camellia sinensis; Cardiovascular Diseases; Carotenoids; Chondroitin; Cimicifuga; Dietary Supplements; Echinacea; Fish Oils; Flax; Glucosamine; Humans; Inflammatory Bowel Diseases; Lutein; Lycopene; Neoplasms; Plant Preparations; Primary Health Care; Primary Prevention; Probiotics; Silybum marianum; United States; Vaccinium macrocarpon; Zingiber officinale

2008